The Development of a New Medicine
Design of Clinical Trials for Treatment of Invasive Fungal Infections John H. Powers, MD FACP FIDSA Senior Medical Scientist SAIC in support of Collaborative.
The importance of international experience. An ESMO ...
Kuliah AKI 2007
Standards-Setting in the Context of Regulatory Harmonization Carolyn Compton, M.D., Ph.D., CEO and President Critical Path Institute (C-Path) IOM Workshop.
1 Workshop on Adaptive Treatment Strategies Janet Levy, Ph.D. Jim McKay, Ph.D. Carl Pieper, Dr.Ph. Madhukar Trivedi, M.D.
PREVENTING RELAPSE Lee B. Reichman, MD, MPH Northeast TB Controllers Meeting October 24, 2006 Princeton, New Jersey.
Modeling and simulation (M&S) was employed to recommend doses for human Phase I studies of a direct Factor Xa (FXa) inhibitor, CS-3030. Predicted human.
Design of Clinical Trials for Select Patients With a Rising PSA following Primary Therapy Anthony V. D’Amico, MD, PhD Professor of Radiation Oncology Harvard.
Involving people with stroke in stroke research Nina Fudge Chris McKevitt Stroke Research Patients and Family Group.
PREVENTING RELAPSE
Workshop on Adaptive Treatment Strategies
